India's drug regulator has approved Itolizumab, a drug used to cure skin ailment psoriasis for "restricted emergency use" to treat Covid-19 patients with moderate to severe acute respiratory distress, officials told PTI on Friday.
from Times of India https://ift.tt/2ZXAC30
No comments:
Post a Comment